SAINT FLOORING LIMITED
Company number 06489320 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B+ The patient is in robust physical condition, demonstrating strong growth in revenue and a solid capital base. However, there are early symptoms of "cash flow dehydration" that require monitoring. While profitability and asset growth are encouraging, the steady decline in cash reserves over the past three years suggests the business is consuming more liquid resources than it is generating, warranting a proactive check-up on working capital management.
1. Key Vital Signs
- Revenue (Turnover): £22,003,549 (2025)
- Interpretation: The patient's "caloric intake" is excellent and growing. Up from £20.5M in 2024 and £17.7M in 2022, this shows a healthy, expanding business with strong market demand for its flooring solutions.
- Net Assets (Shareholders' Funds): £3,691,779 (2025)
- Interpretation: The company's "muscle mass" is solid. After a slight dip in 2024 (£3.28M), net assets have recovered and grown, indicating retained profitability and a strong equity base.
- Cash Reserves: £1,637,343 (2025)
- Interpretation: The "hydration levels" are causing some concern. Cash has steadily declined from a peak of £2.94M in 2022 to £1.63M in 2025. While still adequate to cover a significant portion of liabilities, this downward trend is a vital sign that needs attention.
- Liabilities: £2,899,344 (2025)
- Interpretation: The "cholesterol levels" are slightly elevated but manageable. Total liabilities have crept up gradually over the last few years, but with a debt-to-equity ratio of roughly 0.78, the company is not over-leveraged.
2. Diagnosis
Symptoms Analysis: The financial data reveals a business that is successfully navigating a changing economic environment. The directors' report notes a strategic pivot towards "build to rent" (BTR) partnerships and investor deals to offset a slowdown in private housing sales. This strategic agility is a sign of excellent corporate "immune system" function, allowing the company to maintain top-line growth despite macroeconomic headwinds.
However, the balance sheet shows a persistent drain on cash reserves over a three-year period, even as turnover has remained above the £20M mark. This suggests that the business might be experiencing margin pressure, increased working capital demands (perhaps funding larger BTR contracts), or significant capital expenditures. The dip in net assets in 2024 followed by a recovery in 2025 shows some volatility in earnings, but the overall trajectory of shareholder funds remains positive.
Overall Condition: The company is fundamentally healthy and profitable. The steady cash decline is not yet at a critical stage, but it is the equivalent of a patient running marathons while slightly neglecting their water intake.
3. Recommendations
- Cash Flow Rehydration Protocol: Implement stricter working capital management. Focus on accelerating debtor collections and carefully managing creditor payment cycles. The company should aim to reverse the downward cash trend in the next financial year.
- Margin Pulse Check: With the shift in client mix towards BTR partnerships, ensure that pricing strategies adequately reflect the costs and risks associated with these larger contracts. Monitor gross profit margins closely to ensure the increased revenue is translating to bottom-line cash generation.
- Forecasting and Monitoring: Given the optimistic projection of "record revenue figures in year ending 2026," establish rolling 13-week cash flow forecasts. This will ensure that the cash reserves are sufficient to support the anticipated growth without requiring external financing.
- Strategic Reserve Building: Consider allocating a fixed percentage of the anticipated 2026 record profits to rebuild the cash buffer to historical levels (closer to the £2.5M - £3M mark), providing a robust safety net for future economic fluctuations.